This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SunLink Health Systems, Inc. Announces Fiscal 2011 Third Quarter And Nine-Month Results

SunLink Health Systems, Inc. (NYSE Amex Equities: SSY) today announced earnings from continuing operations for its fiscal quarter ended March 31, 2011 of $2,515,000, or $0.31 per fully diluted share, compared to earnings from continuing operations of $469,000, or $0.06 per fully diluted share, for the comparable quarter ended March 31, 2010. For the nine months ended March 31, 2011, SunLink reported a loss from continuing operations of $1,849,000, or a loss of $0.23 per fully diluted share, compared to earnings from continuing operations of $691,000, or $0.09 per fully diluted share, for the nine months ended March 31, 2010. Net revenues for the quarter and nine months ended March 31, 2011 include $4,810,000 from Medicare and certain Medicaid Electronic Health Records Incentive Programs (“EHR Incentive Programs”). The results for the nine months ended March 31, 2010 included a pre-tax gain of $2,342,000 from the sale of three home health businesses.

SunLink reported net earnings of $2,683,000, or $0.33 per fully diluted share, for the quarter ended March 31, 2011, compared to net earnings of $1,646,000, or $0.20 per fully diluted share, for the comparable quarter a year ago. For the nine months ended March 31, 2011, SunLink reported a net loss of $1,851,000, or a loss of $0.23 per fully diluted share, compared to net earnings of $1,618,000, or $0.20 per fully diluted share for the comparable period last year.

Consolidated net revenues from continuing operations for the quarter ended March 31, 2011 increased by 7.4% to $52,028,000 compared to $48,462,000 in the comparable period a year ago. The Healthcare Facilities Segment net revenues of $39,337,000 in the current quarter increased $2,797,000, or 7.7%, from the prior year and included $4,810,000 from Medicare and certain Medicaid EHR Incentive Programs. Additional reimbursement under the EHR Incentive Programs is expected to be received through fiscal 2014 if the annual requirements of the programs are met. Also included in net revenues of the Healthcare Facilities Segment for the quarter ended March 31, 2011 is $1,948,000 from state indigent care programs and positive prior year third-party payor settlements compared to $2,614,000 in the quarter ended March 31, 2010. The Specialty Pharmacy Segment net revenues of $12,691,000 in the quarter ended March 31, 2011 increased $769,000, or 6.5% from the prior year. Consolidated net revenues from continuing operations for the nine months ended March 31, 2011 decreased by 1.1% to $137,947,000 compared to $139,551,000 in the comparable period a year ago. The Healthcare Facilities Segment had net revenues in the nine months ended March 31, 2011 of $104,871,000 compared to $105,369,000 last year. The Specialty Pharmacy Segment had $33,076,000 of net revenue for the nine months ended March 31, 2011 compared to $34,182,000 in the comparable period a year ago.

The company reported operating profit from continuing operations for the quarter ended March 31, 2011 of $5,687,000 compared to an operating profit for the quarter ended March 31, 2010 of $1,720,000. The operating profit in the current year increased $3,967,000, primarily due to increased earnings of the Healthcare Facilities Segment’s which included the reimbursement of $4,810,000 under EHR Incentive Programs.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs